financetom
Business
financetom
/
Business
/
Deal trend in Q1CY23: Grant Thornton Bharat report reveals 35-40% decline in value and volume
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deal trend in Q1CY23: Grant Thornton Bharat report reveals 35-40% decline in value and volume
Apr 18, 2023 8:18 AM

The first quarter of this calendar year saw a significant year-on-year decline in both volume and deal value of deals, according to a report by Grant Thornton Bharat. There were 332 deals valued at $9.7 billion, a 46 percent decline in volume and a 35 percent decline in value, the report showed.

Share Market Live

NSE

Following the Russia- Ukraine war, the recent collapse of SVB Bank added further uncertainty amid global recessionary trends.

Despite this, March saw 98 deals amounting to $5.2 billion, a 46 percent decline in volume but an 18 percent increase in value owing to one marquee insolvency transaction — Suraksha Realty’s acquisition of Jaypee Infratech for $2.5 billion.

According to Prashant Mehra, a partner at Grant Thornton Bharat, the sentiment around the world has been quite lackluster, with both values and volumes experiencing a 35-40 percent decline compared to last year.

He said, “I think what's happened in the first quarter of this calendar year is something that was really expected. The sentiment across the globe has been very tepid, which is why we have seen about 35 to 40 percent low last year both in terms of values and volumes.”

Mehra added, “Large deals happening in the first quarter of last year has made this percentage even higher. But yes, just focusing on volumes itself it is about a 30-35 percent de-growth.’

Read Here | Bernstein lists the reasons why it sees limited upside for Delhivery shares

Mergers & Acquisition (M&A) scenario

In the M&A section, 76 deals worth $4.4 billion were recorded. This was 56 percent lower in YOY volumes and a 21 percent decline in values over Q1 2022.

The decline in deal volumes was majorly contributed by 62 percent fall in domestic activity, recording the third-lowest quarterly deal volumes for any given quarter since 2011 on back of the wait and watch approach around budget 2023 announcement.

The start-up sector continued to lead the deal activity with 22 percent of the deals, followed by the IT and pharma sectors accounting for 28 percent of overall M&A volumes for the quarter, according to the Grant Thornton report.

Driven by Jaypee Infratech’s acquisition by Suraksha Realty, the real estate sector accounted for 55 percent of the quarter’s values amounting to $2.5 billion.

Mehra mentioned that it is encouraging to see that deals in both M&A and private equity are spread out across different sectors, including industrial, pharma, and real estate. While private equity has typically focused on the technology sector, this diversification is a positive development.

He stated that there is no one sector that stands out as a clear favorite, the deals are across. The fact that deals are happening across sectors shows that the market is still interested in transactions, but weak sentiment means it's a wait-and-watch situation.

PE activity also witnessed a declining trend, by 42 percent (volumes) and 44 percent (values), recording 256 deals worth $5.3 billion. The start-up sector occupied the larger share of volumes with 60 percent of the deals followed by investment in e-commerce and IT sectors. Driven by four high-value deals (valued at and above $100 million), e-commerce sector accounted for 30 percent of the quarter's deal values amounting to $1.3 billion.

However, signs of pre-deal activity in late March or early April suggest a turning point, and hopefully, the market will improve in the next few months.

Regarding block deals, it's uncertain whether they will continue because buying is more appropriate when valuations are low, rather than selling, said Mehra.

Read Here | Avalon Technologies IPO: Shares debut on Dalal Street at Rs 431 apiece

With India's growth potential and the current tepid and wait-and-watch global environment, the markets are expected to turn around in a quarter or so.

Afterward, IPOs will return, and people will focus on investing more money rather than monetising existing investments. Action is expected to pick up in June, and growth is expected to exceed last year's levels starting in July.

(Edited by : Pradeep John)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved